Copper(I) fluoroalkoxidecomplexes bearing dinitrogen ligands were synthesized and the structure and reactivity of the complexes toward trifluoroethoxylation, pentafluoropropoxylation, and tetrafluoropropoxylation of aryl and heteroarylbromides were investigated.
Transition-Metal-Mediated Synthesis of Trifluoroethyl Aryl Ethers
作者:Zhiqiang Weng、Yangjie Huang、Ronglu Huang
DOI:10.1055/s-0035-1560054
日期:——
A series of well-definedcopper(I) fluoroalkoxidecomplexes, [(phen)2Cu][OCH2RF], have been shown to undergo trifluoroethoxylation, pentafluoropropoxylation, and tetrafluoropropoxylation with aryl and heteroarylbromides to generate the corresponding trifluoroethyl, pentafluoropropyl, and tetrafluoropropyl (hetero)aryl ethers in good to excellent yields. The reaction tolerates a variety of functional
Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
申请人:Lowe Adams John
公开号:US20050256162A1
公开(公告)日:2005-11-17
The present invention relates to novel fluoroalkoxybenzylamino derivatives of nitrogen containing heterocyclic compounds, and specifically, to compounds of the formula
wherein Q, X
1
, X
2
and X
3
are as defined below. These novel compounds are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders.
Fluoroalkyoxybenzylamino derivatives of nitrogen containing heterocycles
申请人:——
公开号:US20030199540A1
公开(公告)日:2003-10-23
The present invention relates to novel fluoroalkoxybenzylamino derivatives of nitrogen containing heterocyclic compounds, and specifically, to compounds of the formula
1
wherein Q, X
1
, X
2
and X
3
are as defined below. These novel compounds are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders.
Use of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles as substance P receptor antagonists
申请人:Pfizer Products Inc.
公开号:EP1172106A2
公开(公告)日:2002-01-16
The present invention relates to methods of treating various CNS and other disorders by adminstering fluoroalkoxybenzylamino derivatives of nitrogen containing heterocyclic compounds, and specifically, by administering compounds of the formula
wherein Q, X1, X2 and X3 are as defined below, and their pharmaceutically acceptable salts.